Screener
PTC Therapeutics PTCT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
FAQ
- What is PTC Therapeutics's free cash flow?
- PTC Therapeutics (PTCT) reported free cash flow of -$60.24M in Q1 2026.
- How has PTC Therapeutics's free cash flow changed year-over-year?
- PTC Therapeutics's free cash flow decreased by 106.9% year-over-year, from $868.38M to -$60.24M.
- What is the long-term trend for PTC Therapeutics's free cash flow?
- Over 3 years (2021 to 2024), PTC Therapeutics's free cash flow has grown at a -25.8% compound annual growth rate (CAGR), from -$279.55M to -$114.19M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about PTC Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude